Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryuzo Ueda

Showing results (11-20 of 333) with videos related to

Pageof 34
Sort By:
International Journal of Hematology|October 14, 2011
Antibody therapy for Adult T-cell leukemia-lymphomaTakashi Ishida, Ryuzo Ueda
Cancer Science|November 4, 2010
Immunopathogenesis of lymphoma: focus on CCR4Takashi Ishida, Ryuzo Ueda
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 30, 2002
[Monoclonal antibody for cancer treatment]Hiroyuki Achiwa, Shigeki Sato, Ryuzo Ueda
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|November 10, 2009
[The role of physicians in charge of cancer chemotherapy in oncological management]Shigeru Kusumoto, Hirokazu Komatsu, Ryuzo Ueda
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|August 22, 2002
[A case of multiple myeloma with infiltration into skeletal muscle after injections of a granulocyte-colony stimulating-factor]Motoo Kikuchi, Toshiaki Inagaki, Ryuzo Ueda
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|May 8, 2015
[Development of mogamulizumab and establishment of an optimal therapy based on genomic biomarkers: from the academic viewpoint]Shinsuke Iida, Takashi Ishida, Ryuzo Ueda
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|September 25, 2004
[CD5- CD11c+ CD23- small lymphocytic lymphoma evolving from aplastic anemia]Motoo Kikuchi, Toshiaki Inagaki, Ryuzo Ueda
International Journal of Cardiology|June 9, 2006
Association among C-reactive protein, oxidative stress, and traditional risk factors in healthy Japanese subjectsYasuaki Dohi, Hiroyuki Takase, Koichi Sato, et al.
International Journal of Rheumatology|May 1, 2012
The Th17/IL-23 Axis and Natural Immunity in Psoriatic ArthritisShinji Maeda, Yoshihito Hayami, Taio Naniwa, et al.
Haematologica|January 19, 2007
Induction of class II major histocompatibility complex expression in human multiple myeloma cells by retinoidTakaomi Sanda, Shinsuke Iida, Satoshi Kayukawa, et al.
Pageof 34

Showing results (11-20 of 333) with videos related to

Sort By:
Pageof 34
International Journal of Hematology|October 14, 2011
Antibody therapy for Adult T-cell leukemia-lymphomaTakashi Ishida, Ryuzo Ueda
Cancer Science|November 4, 2010
Immunopathogenesis of lymphoma: focus on CCR4Takashi Ishida, Ryuzo Ueda
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 30, 2002
[Monoclonal antibody for cancer treatment]Hiroyuki Achiwa, Shigeki Sato, Ryuzo Ueda
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|November 10, 2009
[The role of physicians in charge of cancer chemotherapy in oncological management]Shigeru Kusumoto, Hirokazu Komatsu, Ryuzo Ueda
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|August 22, 2002
[A case of multiple myeloma with infiltration into skeletal muscle after injections of a granulocyte-colony stimulating-factor]Motoo Kikuchi, Toshiaki Inagaki, Ryuzo Ueda
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|May 8, 2015
[Development of mogamulizumab and establishment of an optimal therapy based on genomic biomarkers: from the academic viewpoint]Shinsuke Iida, Takashi Ishida, Ryuzo Ueda
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|September 25, 2004
[CD5- CD11c+ CD23- small lymphocytic lymphoma evolving from aplastic anemia]Motoo Kikuchi, Toshiaki Inagaki, Ryuzo Ueda
International Journal of Cardiology|June 9, 2006
Association among C-reactive protein, oxidative stress, and traditional risk factors in healthy Japanese subjectsYasuaki Dohi, Hiroyuki Takase, Koichi Sato, et al.
International Journal of Rheumatology|May 1, 2012
The Th17/IL-23 Axis and Natural Immunity in Psoriatic ArthritisShinji Maeda, Yoshihito Hayami, Taio Naniwa, et al.
Haematologica|January 19, 2007
Induction of class II major histocompatibility complex expression in human multiple myeloma cells by retinoidTakaomi Sanda, Shinsuke Iida, Satoshi Kayukawa, et al.
Pageof 34